SNS Financial Group’s Enzo Biochem, Inc. ENZ Stock Holding History

SNS Financial Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-62,500	Closed	-$89.4K	–	204
2022 Q4	$89.4K	Hold	62,500	–	–	0.01%	191
2022 Q3	$139K	Hold	62,500	–	–	0.02%	178
2022 Q2	$129K	Hold	62,500	–	–	0.02%	184
2022 Q1	$181K	Buy	+62,500	New	+$201K	0.02%	205
2021 Q1	–	Sell	-10,513	Closed	-$26K	–	226
2020 Q4	$26K	Hold	10,513	–	–	﹤0.01%	204
2020 Q3	$22K	Buy	+10,513	New	+$25K	﹤0.01%	202

Other funds holding ENZ

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

SNS Financial Group's ENZ Position: Q1 2023 in Review

SNS Financial Group sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 62,500 shares — an estimated $89.4K sold.

SNS Financial Group first reported a position in ENZ in Q3 2020 and held it in 6 quarters. The position peaked at $181K in Q1 2022. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

SNS Financial Group reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
SNS Financial Group sold 62,500 Enzo Biochem, Inc. shares in Q1 2023, an estimated $89.4K.
SNS Financial Group first reported a position in Enzo Biochem, Inc. in Q3 2020 and held it in 6 quarters.
SNS Financial Group's Enzo Biochem, Inc. position peaked at $181K in Q1 2022.
52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on SNS Financial Group's 13F filing for Q1 2023, filed 28 Apr 2023.